1.
Journal of Biological Regulators and Homeostatic Agents
; 36(2S4):13-18, 2022.
Article
in English
| EMBASE | ID: covidwho-2205222
ABSTRACT
Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicry between the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further our understanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a high degree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63. Copyright © by BIOLIFE, s.a.s.